Human Reproduction, Vol 12, 542-547, Copyright © 1997 by Oxford University Press
G Horne, JD Critchlow, MC Newman, L Edozien, PL Matson and BA Lieberman
A total of 364 consecutive patients requesting in-vitro fertilization (IVF)
treatment were divided randomly into two groups. In the first group, two
embryos in the original IVF cycle were allowed to divide prior to transfer,
with any remaining embryos being cryopreserved at the pronucleate (PN)
stage. In the second group, all the embryos were allowed to divide to the
early cleavage (EC) stage, and the best two replaced; any suitable
remaining embryos were frozen at the 2- to 4- cell stage. A total of 134
cycles (36.8%) fulfilled the study criteria for a fresh embryo replacement
and supernumerary embryos cryopreserved. In the PN group, 72 out of 182
(39.6%) patients had a fresh embryo replacement accompanied by embryo
cryopreservation, which was not significantly different from the EC group
(62/182; 34.1%). The livebirth rate per fresh embryo transfer in the EC
group (17/62; 27.4%) was significantly higher than that for the PN group
(8/72; 11.1%; P < 0.05). Embryo survival following thawing was similar
for the PN (96/129; 74.4%) and EC (79/102; 77.4%) stages. Although not
significant, the livebirth rate following the transfer of thawed embryos
was higher in the PN group (11/44; 25.0%) than in the EC group (4/38;
10.5%). Following one fresh and two freeze-thaw embryo replacements, the
observed cumulative viable pregnancy rates were comparable for patients in
both the PN (40.2%) and EC (41.1%) groups.
ARTICLES
A prospective evaluation of cryopreservation strategies in a two-embryo transfer programme
Department of Reproductive Medicine, St Mary's Hospital, Manchester, UK.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Griesinger, S. von Otte, A. Schroer, A.K. Ludwig, K. Diedrich, S. Al-Hasani, and A. Schultze-Mosgau Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study Hum. Reprod., May 1, 2007; 22(5): 1348 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Nawroth and M. Ludwig What is the 'ideal' duration of progesterone supplementation before the transfer of cryopreserved-thawed embryos in estrogen/progesterone replacement protocols? Hum. Reprod., May 1, 2005; 20(5): 1127 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Horne, A.D. Atkinson, E.H.E. Pease, J.P. Logue, D.R. Brison, and B.A. Lieberman Live birth with sperm cryopreserved for 21 years prior to cancer treatment: Case report Hum. Reprod., June 1, 2004; 19(6): 1448 - 1449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Salumets, T. Tuuri, S. Makinen, S. Vilska, L. Husu, R. Tainio, and A.-M. Suikkari Effect of developmental stage of embryo at freezing on pregnancy outcome of frozen-thawed embryo transfer Hum. Reprod., September 1, 2003; 18(9): 1890 - 1895. [Abstract] [Full Text] [PDF]
|
|